Undisclosed Dual Amylin and Calcitonin Receptor Agonist
/ Viking Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 11, 2026
IND for Dual Amylin and Calcitonin Receptor Agonist (DACRA) Planned for 1Q26.
(PRNewswire)
- "The company has been developing a series of potent agonists of the amylin and calcitonin receptors, which could play an important role as both single agents or in combination with GLP-1 or dual GLP-1/GIP agonists."
IND • Obesity
1 to 1
Of
1
Go to page
1